Labcorp Holdings (LTS:0JSY) Current Accrued Expense: $862 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0JSY Labcorp Holdings Inc LTS:0JSY
79 GF Score
Price $311.26
GF Value $275.97
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Labcorp Holdings Current Accrued Expense?

Labcorp Holdings LTS:0JSY +0.59% 79 Current Accrued Expense is $862 Mil as of Jun. 2026. GuruFocus rates LTS:0JSY with a GF Score™ of 79/100 and a GF Value™ of $275.97 (Modestly Overvalued). The stock has 7 warning signs investors should review.

Labcorp Holdings's Current Accrued Expense for the quarter that ended in Jun. 2026 was $862 Mil.

Labcorp Holdings's quarterly Current Accrued Expense increased from Dec. 2025 ($264 Mil) to Mar. 2026 ($852 Mil) and increased from Mar. 2026 ($852 Mil) to Jun. 2026 ($862 Mil).

Labcorp Holdings's annual Current Accrued Expense declined from Dec. 2023 ($245 Mil) to Dec. 2024 ($223 Mil) but then increased from Dec. 2024 ($223 Mil) to Dec. 2025 ($264 Mil).

Labcorp Holdings Current Accrued Expense Related Terms

Labcorp Holdings Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for Labcorp Holdings's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Labcorp Holdings Current Accrued Expense Chart

Labcorp Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 429.00 236.80 245.10 223.10 263.60

Labcorp Holdings Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 835.80 878.00 263.60 851.90 862.40
LTS:0JSY
79GF Score
Labcorp Holdings Inc LTS:0JSY
Current Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Labcorp Holdings Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of $862 Mil mean?
Labcorp Holdings (LTS:0JSY) has a Current Accrued Expense of $862 Mil as of Jun. 2026. Current Accrued Expense records the total amount of accrued expenses. View historical data on Labcorp Holdings and its competitors.
Is Labcorp Holdings' Current Accrued Expense too high?
Labcorp Holdings' current Current Accrued Expense is $862 Mil. Overall, Labcorp Holdings has a GF Score™ of 79/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Labcorp Holdings' Current Accrued Expense compare to DGX and MTD?
Labcorp Holdings' Current Accrued Expense of $862 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Medical Diagnostics & Research company?
A good Current Accrued Expense depends on the Medical Diagnostics & Research industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on Labcorp Holdings and its competitors. Labcorp Holdings's current Current Accrued Expense is $862 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labcorp Holdings stock overvalued right now?
Based on GuruFocus' analysis, Labcorp Holdings (LTS:0JSY) is currently considered Modestly Overvalued. The stock's GF Value™ is $275.97, compared to a current price of $311.26 — trading 12.8% above its estimated fair value. The current Current Accrued Expense is $862 Mil. Labcorp Holdings' overall GF Score™ is 79/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For Labcorp Holdings (LTS:0JSY), the current Current Accrued Expense is $862 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Labcorp Holdings (LTS:0JSY) Overvalued in 2026?

Based on GuruFocus' analysis, Labcorp Holdings stock appears to be overvalued. The current stock price of $311.26 is trading 12.8% above its estimated GF Value™ of $275.97. GuruFocus considers Labcorp Holdings to be Modestly Overvalued.

Key valuation signals for LTS:0JSY:

  • Current Accrued Expense: $862 Mil
  • GF Value™: $275.97 vs. price of $311.26 (12.8% above fair value)
  • GF Score™: 79/100 with 7 warning signs

No single metric tells the full story. See the LTS:0JSY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Labcorp Holdings Business Description

Other Exchanges LH:USAN6B:Germany
Address 358 South Main Street, Burlington, NC, USA, 27215
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.
79GF Score

Get the complete analysis for LTS:0JSY

Current Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$311.26
Price
$275.97
GF Value